25 Healthcare Stocks Moving In Wednesday’s Pre-Market Session

Gainers

• Viveve Medical, Inc. (NASDAQ: VIVE) shares surged 49.3% to $2.03 during Wednesday’s pre-market session. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
• Streamline Health Solns, Inc. (NASDAQ: STRM) stock surged 30.4% to $1.50.
• CytoSorbents, Inc. (NASDAQ: CTSO) stock moved upwards by 9.3% to $5.90.
• resTORbio, Inc. (NASDAQ: TORC) stock increased by 8.3% to $1.44.
• Genprex, Inc. (NASDAQ: GNPX) stock rose 8.2% to $5.30.
• Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) shares moved upwards by 7.5% to $0.85.
• Co-Diagnostics, Inc. (NASDAQ: CODX) shares moved upwards by 6.8% to $3.12.
• Applied Genetic Tech, Inc. (NASDAQ: AGTC) shares surged 6.8% to $5.77. The most recent rating by Roth Capital, on January 28, is at Buy, with a price target of $25.00.
• Brickell Biotech, Inc. (NASDAQ: BBI) shares increased by 6.0% to $1.75.
• VIVUS, Inc. (NASDAQ: VVUS) stock increased by 4.7% to $2.66.
• Cellectar Biosciences, Inc. (NASDAQ: CLRB) shares increased by 4.1% to $3.30. The most recent rating by Roth Capital, on January 21, is at Buy, with a price target of $10.00.
• Teladoc Health, Inc. (NYSE: TDOC) shares surged 4.0% to $122.00. The most recent rating by Wells Fargo, on February 12, is at Equal-Weight, with a price target of $105.00.
• DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) stock moved upwards by 3.9% to $0.57.
• ADMA Biologics, Inc. (NASDAQ: ADMA) stock increased by 3.8% to $3.85.
• Teligent, Inc. (NASDAQ: TLGT) shares rose 3.7% to $0.56.
• Agenus, Inc. (NASDAQ: AGEN) shares moved upwards by 3.6% to $4.04.
• Xenetic Biosciences, Inc. (NASDAQ: XBIO) stock surged 3.4% to $1.23.
• Karyopharm Therapeutics, Inc. (NASDAQ: KPTI) shares surged 3.2% to $16.87. According to the most recent rating by Wedbush, on January 17, the current rating is at Neutral.
• Rockwell Medical, Inc. (NASDAQ: RMTI) stock rose 3.1% to $2.99.
• Valeritas Holdings, Inc. (NASDAQ: VLRX) shares moved upwards by 3.1% to $0.30. According to the most recent rating by Oppenheimer, on December 23, the current rating is at Perform.

Losers

• Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares fell 9.3% to $8.35 during Wednesday’s pre-market session.
• Tocagen, Inc. (NASDAQ: TOCA) stock fell 4.0% to $0.52.
• Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) stock decreased by 3.6% to $0.24.
• Vaxart, Inc. (NASDAQ: VXRT) stock declined 3.6% to $1.06.
• Bausch Health Companies, Inc. (NYSE: BHC) shares declined 2.6% to $27.35. The most recent rating by Morgan Stanley, on February 12, is at Overweight, with a price target of $32.00.